Cargando…
The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review
The incidence of venous thromboembolism (VTE) events in patients with COVID-19 treated with a standard thromboprophylaxis dose of anticoagulants remains high. We conducted a systematic review in order to explore the association between therapeutic-dose anticoagulation and its effect on mortality in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791436/ https://www.ncbi.nlm.nih.gov/pubmed/33079569 http://dx.doi.org/10.1177/1076029620960797 |
_version_ | 1783633603919347712 |
---|---|
author | Wijaya, Indra Andhika, Rizky Huang, Ian |
author_facet | Wijaya, Indra Andhika, Rizky Huang, Ian |
author_sort | Wijaya, Indra |
collection | PubMed |
description | The incidence of venous thromboembolism (VTE) events in patients with COVID-19 treated with a standard thromboprophylaxis dose of anticoagulants remains high. We conducted a systematic review in order to explore the association between therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19. A systematic search was carried out using the electronic databases of PubMed, EuropePMC, and the Cochrane Central Database, using specific keywords. All articles that fulfilled the inclusion criteria were included in the qualitative analysis. There were 8 observational studies included in the final qualitative analysis. Quality assessment using the Newcastle-Ottawa Scale (NOS) showed a mean score of 7.5 ± 1.06, indicating moderate to high quality of the studies. Three retrospective cohort studies reported a reduction in the mortality rate, while 6 other studies showed no mortality benefits among patients with COVID-19 treated with therapeutic-dose anticoagulation. There was a slight tendency toward a reduction in the mortality rate among mechanically-ventilated patients with COVID-19 receiving therapeutic-dose anticoagulation. Bleeding events and thrombotic complications among patients receiving therapeutic-dose anticoagulation were reported in 3 studies. Although it is too soon to draw any conclusions, this systematic review draws attention to current evidence regarding the association between therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19. |
format | Online Article Text |
id | pubmed-7791436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77914362021-01-15 The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review Wijaya, Indra Andhika, Rizky Huang, Ian Clin Appl Thromb Hemost Original Article The incidence of venous thromboembolism (VTE) events in patients with COVID-19 treated with a standard thromboprophylaxis dose of anticoagulants remains high. We conducted a systematic review in order to explore the association between therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19. A systematic search was carried out using the electronic databases of PubMed, EuropePMC, and the Cochrane Central Database, using specific keywords. All articles that fulfilled the inclusion criteria were included in the qualitative analysis. There were 8 observational studies included in the final qualitative analysis. Quality assessment using the Newcastle-Ottawa Scale (NOS) showed a mean score of 7.5 ± 1.06, indicating moderate to high quality of the studies. Three retrospective cohort studies reported a reduction in the mortality rate, while 6 other studies showed no mortality benefits among patients with COVID-19 treated with therapeutic-dose anticoagulation. There was a slight tendency toward a reduction in the mortality rate among mechanically-ventilated patients with COVID-19 receiving therapeutic-dose anticoagulation. Bleeding events and thrombotic complications among patients receiving therapeutic-dose anticoagulation were reported in 3 studies. Although it is too soon to draw any conclusions, this systematic review draws attention to current evidence regarding the association between therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19. SAGE Publications 2020-10-20 /pmc/articles/PMC7791436/ /pubmed/33079569 http://dx.doi.org/10.1177/1076029620960797 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Wijaya, Indra Andhika, Rizky Huang, Ian The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review |
title | The Use of Therapeutic-Dose Anticoagulation and Its Effect on
Mortality in Patients With COVID-19: A Systematic Review |
title_full | The Use of Therapeutic-Dose Anticoagulation and Its Effect on
Mortality in Patients With COVID-19: A Systematic Review |
title_fullStr | The Use of Therapeutic-Dose Anticoagulation and Its Effect on
Mortality in Patients With COVID-19: A Systematic Review |
title_full_unstemmed | The Use of Therapeutic-Dose Anticoagulation and Its Effect on
Mortality in Patients With COVID-19: A Systematic Review |
title_short | The Use of Therapeutic-Dose Anticoagulation and Its Effect on
Mortality in Patients With COVID-19: A Systematic Review |
title_sort | use of therapeutic-dose anticoagulation and its effect on
mortality in patients with covid-19: a systematic review |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791436/ https://www.ncbi.nlm.nih.gov/pubmed/33079569 http://dx.doi.org/10.1177/1076029620960797 |
work_keys_str_mv | AT wijayaindra theuseoftherapeuticdoseanticoagulationanditseffectonmortalityinpatientswithcovid19asystematicreview AT andhikarizky theuseoftherapeuticdoseanticoagulationanditseffectonmortalityinpatientswithcovid19asystematicreview AT huangian theuseoftherapeuticdoseanticoagulationanditseffectonmortalityinpatientswithcovid19asystematicreview AT wijayaindra useoftherapeuticdoseanticoagulationanditseffectonmortalityinpatientswithcovid19asystematicreview AT andhikarizky useoftherapeuticdoseanticoagulationanditseffectonmortalityinpatientswithcovid19asystematicreview AT huangian useoftherapeuticdoseanticoagulationanditseffectonmortalityinpatientswithcovid19asystematicreview |